Ascletis Pharma Balance Sheet Health
Financial Health criteria checks 6/6
Ascletis Pharma has a total shareholder equity of CN¥2.2B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥2.3B and CN¥95.8M respectively.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥2.09b |
| Equity | CN¥2.18b |
| Total liabilities | CN¥95.79m |
| Total assets | CN¥2.28b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 2VJ's short term assets (CN¥2.1B) exceed its short term liabilities (CN¥86.8M).
Long Term Liabilities: 2VJ's short term assets (CN¥2.1B) exceed its long term liabilities (CN¥9.0M).
Debt to Equity History and Analysis
Debt Level: 2VJ is debt free.
Reducing Debt: 2VJ has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: 2VJ has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: 2VJ has sufficient cash runway for more than 3 years if free cash flow continues to reduce at historical rates of 9.4% each year